IONS Stock Analysis Overview
What this means: InvestorsObserver gives Ionis Pharmaceuticals (IONS) an overall rank of 38, which is below average. Ionis Pharmaceuticals is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 38 means that 62% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
IONS Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
IONS Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
IONS Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
IONS Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
IONS Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
IONS Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
IONS Stock Analysis Overview
What this means: InvestorsObserver gives Ionis Pharmaceuticals (IONS) an overall rank of 38, which is below average. Ionis Pharmaceuticals is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 38 means that 62% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.